TR200000906T2 - Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. - Google Patents
Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler.Info
- Publication number
- TR200000906T2 TR200000906T2 TR2000/00906T TR200000906T TR200000906T2 TR 200000906 T2 TR200000906 T2 TR 200000906T2 TR 2000/00906 T TR2000/00906 T TR 2000/00906T TR 200000906 T TR200000906 T TR 200000906T TR 200000906 T2 TR200000906 T2 TR 200000906T2
- Authority
- TR
- Turkey
- Prior art keywords
- methods
- serine
- threonine protein
- protein kinase
- azaquinoxaline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Mevcut bulus kismen 5-azakuinoksalin-bazli bilesikler ile serin/threonin protein kinazlarin fonksiyonunun modüle edilmesi yöntemlerine yöneliktir. Yöntemler RAF gibi bir serin/threonin protein kinazi üreten hücreleri içerir. Buna ek olarak, bulus burada tarif edilen yöntemler ile belirlenen bir bilesik ile organizmalardaki serin/threonin protein kinaz ile ilgili anormal durumlarin önlenmesi ve tedavi edilmesi yöntemlerini tarif eder. Ayrica, bulus, bulusun yöntemleri ile belirlenen bilesiklerden olusan farmasötik bilesimler ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6112397P | 1997-10-06 | 1997-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000906T2 true TR200000906T2 (tr) | 2000-11-21 |
Family
ID=22033733
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00385T TR200100385T2 (tr) | 1997-10-06 | 1998-10-05 | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. |
TR2000/00906T TR200000906T2 (tr) | 1997-10-06 | 1998-10-05 | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00385T TR200100385T2 (tr) | 1997-10-06 | 1998-10-05 | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. |
Country Status (31)
Country | Link |
---|---|
US (2) | US6180631B1 (tr) |
EP (1) | EP1028729B1 (tr) |
JP (1) | JP2001518496A (tr) |
KR (1) | KR100633270B1 (tr) |
CN (1) | CN1169527C (tr) |
AR (1) | AR013542A1 (tr) |
AT (1) | ATE336250T1 (tr) |
AU (1) | AU757585B2 (tr) |
BG (1) | BG64969B1 (tr) |
BR (1) | BR9814814A (tr) |
CA (1) | CA2306257C (tr) |
CY (1) | CY1106223T1 (tr) |
CZ (1) | CZ298775B6 (tr) |
DE (1) | DE69835612T2 (tr) |
DK (1) | DK1028729T3 (tr) |
ES (1) | ES2268791T3 (tr) |
HK (1) | HK1031836A1 (tr) |
HU (1) | HUP0100302A3 (tr) |
IL (2) | IL135103A0 (tr) |
MX (1) | MXPA03011007A (tr) |
NO (1) | NO316598B1 (tr) |
NZ (1) | NZ503431A (tr) |
PL (1) | PL192039B1 (tr) |
PT (1) | PT1028729E (tr) |
RU (1) | RU2223753C2 (tr) |
SK (1) | SK4722000A3 (tr) |
TR (2) | TR200100385T2 (tr) |
TW (1) | TWI245765B (tr) |
UA (1) | UA71555C2 (tr) |
WO (1) | WO1999017759A2 (tr) |
ZA (1) | ZA988961B (tr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA71555C2 (en) | 1997-10-06 | 2004-12-15 | Zentaris Gmbh | Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
AU2725000A (en) * | 1999-01-13 | 2000-08-01 | Bayer Corporation | Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
AU1053501A (en) * | 1999-11-02 | 2001-05-14 | Ajinomoto Co., Inc. | Polyazanaphthalene compound and medicinal use thereof |
US7371763B2 (en) * | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
US20080108672A1 (en) * | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
MXPA04007832A (es) * | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
US7557129B2 (en) * | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
WO2004113274A2 (en) * | 2003-05-20 | 2004-12-29 | Bayer Pharmaceuticals Corporation | Diaryl ureas with kinase inhibiting activity |
PT1636228E (pt) * | 2003-05-23 | 2009-02-02 | Aeterna Zentaris Gmbh | Novas piridopirazinas e sua utilização como moduladores de cinases |
DE102004022383A1 (de) * | 2004-05-06 | 2005-12-01 | Zentaris Gmbh | Neue Pyridopyrazine und deren Verwendung als Modulatoren von Kinasen |
DE10323345A1 (de) | 2003-05-23 | 2004-12-16 | Zentaris Gmbh | Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren |
WO2004110452A1 (en) * | 2003-06-13 | 2004-12-23 | Novartis Ag | 2-aminopyrimidine derivatives as raf kinase inhibitors |
PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
CA2628039A1 (en) | 2005-11-11 | 2007-05-18 | Aeterna Zentaris Gmbh | Novel pyridopyrazines and their use as modulators of kinases |
EP1790342A1 (de) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege |
US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
WO2010003308A1 (zh) * | 2008-07-10 | 2010-01-14 | 卞化石 | 一氧化氮及其信息传递系统在制备恶性肿瘤靶向治疗药物中的应用 |
GB0812969D0 (en) | 2008-07-15 | 2008-08-20 | Sentinel Oncology Ltd | Pharmaceutical compounds |
GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
EP2508184A1 (en) | 2011-04-06 | 2012-10-10 | Æterna Zentaris GmbH | Pyridopyrazine derivatives and their use |
GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118656D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
GB201209613D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
EP2944637B1 (en) * | 2013-01-11 | 2020-02-19 | FUJIFILM Corporation | Nitrogen-containing heterocylic compound or salt thereof |
GB201307577D0 (en) | 2013-04-26 | 2013-06-12 | Astex Therapeutics Ltd | New compounds |
DE102013008118A1 (de) * | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
AU2015238301B2 (en) | 2014-03-26 | 2020-06-25 | Astex Therapeutics Ltd | Combinations |
DK3122359T3 (da) | 2014-03-26 | 2021-03-08 | Astex Therapeutics Ltd | Kombinationer af en fgfr-inhibitor og en igf1r-hæmmer |
JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
AU2015295405B2 (en) | 2014-08-01 | 2020-04-09 | Nuevolution A/S | Compounds active towards bromodomains |
JOP20200201A1 (ar) | 2015-02-10 | 2017-06-16 | Astex Therapeutics Ltd | تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين |
US10478494B2 (en) | 2015-04-03 | 2019-11-19 | Astex Therapeutics Ltd | FGFR/PD-1 combination therapy for the treatment of cancer |
AU2016328692B2 (en) | 2015-09-23 | 2021-03-11 | Janssen Pharmaceutica Nv | New compounds |
MX2018003564A (es) | 2015-09-23 | 2018-06-18 | Janssen Pharmaceutica Nv | 1,4-benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cancer. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001017A (en) * | 1972-12-05 | 1977-01-04 | Ciba-Geigy Ag | Process for the photopolymerization of ethylenically unsaturated compounds |
US4043819A (en) * | 1974-06-11 | 1977-08-23 | Ciba-Geigy Ag | Photo-polymerizable material for the preparation of stable polymeric images and process for making them by photopolymerization in a matrix |
US5217999A (en) | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
DE3804990A1 (de) * | 1988-02-18 | 1989-08-31 | Basf Ag | Herbizid wirksame, heterocyclisch substituierte sulfonamide |
FR2656606B1 (fr) * | 1989-12-28 | 1993-06-25 | Roussel Uclaf | Utilisation de derives du 9,10-dihydrophenanthrene pour la preparation d'un medicament anti-tumoral, application a titre de medicaments de derives du 9,10-dihydrophenanthrene et produits derives de cette structure. |
WO1991015495A1 (en) | 1990-04-02 | 1991-10-17 | Pfizer Inc. | Benzylphosphonic acid tyrosine kinase inhibitors |
US5302606A (en) | 1990-04-16 | 1994-04-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
WO1992020642A1 (en) | 1991-05-10 | 1992-11-26 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
US6194439B1 (en) | 1991-05-29 | 2001-02-27 | Pfizer Inc. | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
HUT71553A (en) | 1992-08-06 | 1995-12-28 | Warner Lambert Co | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
US5330992A (en) | 1992-10-23 | 1994-07-19 | Sterling Winthrop Inc. | 1-cyclopropyl-4-pyridyl-quinolinones |
GB9226855D0 (en) | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
GB9501567D0 (en) | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
US5593997A (en) * | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
US5723462A (en) * | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
UA71555C2 (en) | 1997-10-06 | 2004-12-15 | Zentaris Gmbh | Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives |
GB9726851D0 (en) * | 1997-12-19 | 1998-02-18 | Zeneca Ltd | Human signal transduction serine/threonine kinase |
-
1998
- 1998-05-10 UA UA2000052578A patent/UA71555C2/uk unknown
- 1998-10-01 ZA ZA9808961A patent/ZA988961B/xx unknown
- 1998-10-05 IL IL13510398A patent/IL135103A0/xx not_active IP Right Cessation
- 1998-10-05 NZ NZ503431A patent/NZ503431A/en unknown
- 1998-10-05 SK SK472-2000A patent/SK4722000A3/sk unknown
- 1998-10-05 JP JP2000514630A patent/JP2001518496A/ja not_active Withdrawn
- 1998-10-05 ES ES98948606T patent/ES2268791T3/es not_active Expired - Lifetime
- 1998-10-05 CA CA002306257A patent/CA2306257C/en not_active Expired - Fee Related
- 1998-10-05 PT PT98948606T patent/PT1028729E/pt unknown
- 1998-10-05 HU HU0100302A patent/HUP0100302A3/hu not_active Application Discontinuation
- 1998-10-05 MX MXPA03011007A patent/MXPA03011007A/es not_active IP Right Cessation
- 1998-10-05 TR TR2001/00385T patent/TR200100385T2/tr unknown
- 1998-10-05 TR TR2000/00906T patent/TR200000906T2/tr unknown
- 1998-10-05 US US09/166,723 patent/US6180631B1/en not_active Expired - Fee Related
- 1998-10-05 BR BR9814814-1A patent/BR9814814A/pt not_active Application Discontinuation
- 1998-10-05 RU RU2000111434/15A patent/RU2223753C2/ru not_active IP Right Cessation
- 1998-10-05 PL PL339860A patent/PL192039B1/pl not_active IP Right Cessation
- 1998-10-05 CZ CZ20001129A patent/CZ298775B6/cs not_active IP Right Cessation
- 1998-10-05 WO PCT/US1998/020910 patent/WO1999017759A2/en active IP Right Grant
- 1998-10-05 DE DE69835612T patent/DE69835612T2/de not_active Expired - Fee Related
- 1998-10-05 AU AU95141/98A patent/AU757585B2/en not_active Ceased
- 1998-10-05 KR KR1020007003656A patent/KR100633270B1/ko not_active IP Right Cessation
- 1998-10-05 AT AT98948606T patent/ATE336250T1/de not_active IP Right Cessation
- 1998-10-05 DK DK98948606T patent/DK1028729T3/da active
- 1998-10-05 EP EP98948606A patent/EP1028729B1/en not_active Expired - Lifetime
- 1998-10-05 CN CNB988099403A patent/CN1169527C/zh not_active Expired - Fee Related
- 1998-10-06 TW TW087116559A patent/TWI245765B/zh not_active IP Right Cessation
- 1998-10-06 AR ARP980104970A patent/AR013542A1/es unknown
-
2000
- 2000-03-15 IL IL135103A patent/IL135103A/en unknown
- 2000-04-05 NO NO20001748A patent/NO316598B1/no unknown
- 2000-04-28 BG BG104392A patent/BG64969B1/bg unknown
- 2000-10-16 US US09/688,199 patent/US6727252B1/en not_active Expired - Fee Related
-
2001
- 2001-04-10 HK HK01102529A patent/HK1031836A1/xx not_active IP Right Cessation
-
2006
- 2006-10-30 CY CY20061101554T patent/CY1106223T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000906T2 (tr) | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. | |
NO20001555D0 (no) | Azabenzimidazolbaserte forbindelser for modulering av serin/treonin proteinkinasefunksjon | |
Boavida et al. | Inhibition of phosphatase activity by dissolved humic substances and hydrolytic reactivation by natural ultraviolet light | |
ATE441418T1 (de) | Verwendung von treprostinil zur verbesserung der nierenfunktion | |
CO5640039A2 (es) | Compuesto de pirazol-amida sustituidos utiles como inhibidores de cinasa | |
HN1998000143A (es) | Tetrahidronaftalenos substituidos y compuestos analogos. | |
DE59914754D1 (de) | Verwendung von dispersionen silylterminierter polymerer als dichtmassen | |
BR9714377B1 (pt) | compostos derivados de 3-tiocarbamoilpirazol, seus processos de preparaÇço, uso, assim como pesticidas contendo referidos compostos. | |
ATE336509T1 (de) | Verwendung von taci als antitumormittel | |
TR199901276T2 (tr) | Farnezil protein transferaz inhibisyonu için yararli bilesikler. | |
EA200100139A1 (ru) | Фармацевтические композиции, содержащие 2-хинолоны | |
TR199900843A2 (tr) | Sübstitüe edilmis trisiklik bilesikler. | |
ATE26835T1 (de) | Tris(piperidylaminotriazylamino) verbindungen, ihre herstellung und ihre verwendung als stabilisierungsmittel fuer polymere. | |
ATE220679T1 (de) | Porphyrine und ihre verwendung als photosensitizer | |
DE60019550D1 (de) | Dämpfwachsperlen zur herstellung von festen formgegenständen | |
WO2001021771A3 (en) | Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents | |
BR0016547A (pt) | Composição para a modulação e inibição da permeabilidade vascular (vp) | |
ES2153748A1 (es) | Mezcla sinergica de estabilizadores a base de compuestos de polialquil-1-1-oxa-diaza-espirodecano. | |
DE50000504D1 (de) | Ionische flüssigkeiten, ihre herstellung und ihre verwendung | |
DE60306371D1 (en) | Amorphe feste modifikation von bis(2,4-dicumylphenyl) pentaerythritdiphosphit | |
AU1792697A (en) | Photosensitive composition | |
TR200000624T2 (tr) | Bir enzimin etkinliğinin arttırılması ile ilgili bir yöntem. | |
DE3879478D1 (de) | Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen. | |
DE50003001D1 (de) | Verwendung von porphyrinderivaten in aquarien | |
DE60108089D1 (de) | Heterozyclische oder benzol derivate von liponsäure, deren herstellung und deren verwendung als heilmittel |